Surgical Robotics Technology

Inselspital University Hospital Bern, Switzerland Adopts Asensus Surgical’s Senhance Surgery

asensus-surgical

Asensus Surgical, a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, announced that Inselspital, University Hospital Bern, Switzerland has initiated its Senhance® Surgical System program. This is the second of two new agreements with two hospitals in Europe thus far in 2021, as previously announced in our May 11, 2021 news release.

“Inselspital University Hospital in Bern is the largest University hospital group in Switzerland,” Anthony Fernando, Asensus Surgical President and CEO, says. “We are very pleased they have started surgery with Senhance this week.’’ The University department of visceral surgery – Abdominal Center Inselspital – (upper gastrointestinal and bariatric) department is implementing the digital Senhance platform in their daily surgical practice and will study its clinical utility over the coming months.

Asensus Surgical’s technology platform, Senhance® Surgical System, is the first of its kind digital laparoscopic platform that leverages augmented intelligence to provide unmatched performance and patient outcomes through machine learning. Senhance goes beyond the typical surgical robotic systems, providing surgical assurance through haptic feedback, Eye-tracking camera control, and 3D visualization, and is the first platform to offer 3 mm instruments (the smallest instrument available in the world on a robotic surgical platform).

Surgical Robotics Technology

  • 1 TW Alexander Drive, Suite 160, Durham, NC 27703
  • +1 919-765-8400
  • 1 TW Alexander Drive, Suite 160, Durham, NC 27703
  • +1 919-765-8400
Visit Website View Profile
Sign Up To Our Newsletter